Objective: To report and analyze the mutations of the double-stranded RNA-specific adenosine deaminase (DSRAD) gene in 2 Chinese pedigrees with dyschromatosis symmetrica hereditaria (DSH).
D
YSCHROMATOSIS SYMMETrica hereditaria (DSH) (OMIM 127400), also called reticulate acropigmentation of Dohi, 1 was first described by Toyama 2 in a Japanese family in 1929. The main features of DSH are many hyperpigmented and hypopigmented macules with a variety of diameters on the dorsal aspects of the extremities. The skin lesions appear in infancy or early childhood and commonly cease before adolescence. 3 They last for life. The disease is transmitted as an autosomal dominant pattern or in an autosomal recessive form, 4, 5 and sporadic DSH has been reported. 3 Mainly, DSH occurs in Japanese and Chinese populations, with a few cases described among Koreans, Indians, Europeans, and South Americans. 3, 6 Histologically, there is increased melanin pigmentation in the basal cells of hyperpigmented lesions as well as decreased numbers of melanocytes in the hypopigmented macules. 7 Dyschromatosis universalis hereditaria (DUH) (OMIM 127500) is difficult to differentiate from DSH. Originally, DUH was considered to be a generalized form of DSH, but hypopigmented and hyperpigmented macules appear predominantly on the skin of the trunk, neck, and proximal aspects of the extremities. In DUH, skin lesions appear in the first year of life, whereas they tend to develop within the first 6 years in patients with DSH. Furthermore, some pedigrees with DUH appear to show an autosomal recessive inheritance pattern.
In recent months, 2 loci for DSH were found, and the genetic basis of DSH was elucidated. Our previous study 8, 9 mapped the first locus for DSH on chromosome 1q11-1q21. The second locus was thought to be located at chromosome 6q24.2-6q25.2 by Xing et al, 10 but their patients showed dyschromatosis over almost their entire bodies, suggesting DUH. Many scholars believe that the DSH gene is located on chromosome 1 and the DUH gene is located on chromosome 6. In an attempt to clone the DSH gene, Miyamura et al 11 identified mutations of the double-stranded RNA-specific adenosine deaminase (DSRAD) gene responsible for DSH among Japanese families.
The DSRAD gene encodes the enzyme responsible for RNA editing by site-specific deamination of adenosines. The DSRAD protein catalyzes the deamination of adenosine to inosine in double-stranded RNA substrates and induces translation within the nucleus, possibly at the surface of the nucleolus. 12 We directly performed mutation detection of the DSRAD gene in 2 Chinese families with DSH by sequencing and found 2 mutations (c.3513insC and c.3220_3224delGCATC). These 2 frameshift mutations may lead to premature translation termination, and the truncated proteins with no functional activity can be synthesized.
METHODS

STUDY PARTICIPANTS
Two DSH families recruited for this study were identified through probands from Anhui province in a Chinese Han population. They showed an autosomal dominant inheritance pattern (Figure 1 ). Every family member signed a consent form, and the study was approved by the Anhui Medical University Review Board. After obtaining informed consent from all participants, family members received physical examinations by experienced dermatologists. Blood samples were collected from available family members, and genomic DNA was extracted from peripheral blood with a blood kit (Qiagen Inc, Hilden, Germany).
MUTATION ANALYSES OF THE DSRAD GENE
We designed primers that flanked all 15 coding exons and intronexon boundaries of the DSRAD gene using the Web-based version of the Primer 3.0 program (http://www.genome.wi.mit.edu /cgi-bin/primer/primer3_www.cgi). All of the primers were amplified by polymerase chain reaction (PCR). The reactions were performed with a touchdown program in a 15-µL solution that contained 10 ng of genomic DNA, 10mM Tris hydrochloride, 50mM potassium chloride, 25mM magnesium chloride, 0.45mM dinucleoside triphosphate, 0.04µM of each primer, and 0.1 U of HotstarTaq (Qiagen). The PCR conditions were as follows: Taq activation at 95°C for 15 minutes, followed by 40 cycles each having denaturation at 94°C for 40 seconds, annealing at 58°C for 40 seconds, and extension at 72°C for 45 seconds, except that in the first 10 cycles the annealing temperature decreased from 63°C to 56°C by 0.5°C per cycle, and the final extension was at 72°C for 10 minutes. The PCR products were purified using a QIAquick PCR Purification Kit (Qiagen). We sequenced the DSRAD gene using the ABI PRISM 3730 automated sequencer (Applied Biosystems, Foster City, Calif ). Sequence comparisons and analysis were performed using the Phred-PhrapConsed program, version 12.0 (Genome Sciences Department, University of Washington, Howard Hughes Medical Institute, Seattle). In addition, samples from 96 unrelated matched controls were sequenced to exclude the possibility that these were polymorphisms in the DSRAD gene.
RESULTS
CLINICAL FINDINGS
A 3-generation family and a 2-generation family from Anhui province in China with typical DSH features were recruited ( Figure 1 ). Both families showed an autosomal dominant inheritance pattern. Family 1 consisted of 19 individuals and family 2 of 5 individuals. There were 8 affected individuals in family 1 and 2 affected individuals in family 2. The earliest onset of the disease in the 2 families was from ages 6 to 10 years. The proband of family 1, individual II:8, was a 40-year-old man with a longstanding history of both hypopigmented and hyperpigmented macules that presented diffusely on the extremities. In infancy, this individual developed peasized hyperpigmented and hypopigmented macules on the backs of his hands and feet (Figure 2) . The results of laboratory examinations, including blood cell counts, blood chemical analysis, and urinalysis, were normal. Other affected members all had a mixture of hypopigmented and hyperpigmented macules of various sizes on the dorsal aspects of the extremities and no skin cancer history or other abnormalities. Some had small frecklelike pigmented macules on their faces, necks, and cheeks. The proband of family 2, individual II:2, was a 20-yearold woman who had been born following a normal pregnancy and delivery. At age 6 years, she developed a small mixture of hyperpigmented and hypopigmented macules on the backs of her hands and feet that ranged from 0.1 to 0.5 cm in diameter and gradually became prominent. In the summer or after sun exposure, the eruptions would become pronounced. Examination of the proband's mother revealed diffuse hypopigmented and hyperpigmented macules on the backs of her hands and feet. Similar lesions in all affected individuals were seldom distributed on the skin of the trunk. These abnormalities are asymptomatic and do not affect general health.
IDENTIFICATION OF 2 FRAMESHIFT DSRAD GENE MUTATIONS
We found 2 frameshift mutations in our 2 Chinese families with DSH. The results of sequencing the PCR products from probands are shown in Figure 3 . In the proband of family 1, the nucleotide C was inserted between the 3513 and 3514 nucleotide and formed the c. (Arg1171fs) mutation. This frameshift mutation was found within exon 15, confirmed in the other patients, and excluded in the remaining unaffected persons in family 1 ( Figure 3A and B) . Another frameshift mutation was found in exon 13 of the DSRAD gene in family 2. The 5 nucleotides GCATG were deleted from 3220 to 3224, which results in the mutation of c.3220_3224delGCATC (Gly1073fs) (Figure 3C and D) . Sequencing of the PCR product from the proband's mother in family 2 showed the same mutation as in her daughter. These 2 mutations were not detected in the 96 unrelated controls, suggesting that they are not common polymorphisms. These 2 mutations led to frameshift and premature translation termination within exon 15 and exon 13. The truncated proteins with no functional activity would be synthesized from the gene with these 2 frameshift mutations. We describe the amino acid position in DSRAD according to the sequence published on October 5, 2003 (GenBank accession No. 7669471; http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi ?val=7669471&db=Nucleotide&dopt=GenBank).
COMMENT
Dyschromatosis symmetrica hereditaria is a rare hereditary skin disease characterized by a mixture of hyperpigmented and hypopigmented macules of various sizes on the backs of the hands and feet. Variable and infrequent features reported with DSH include large, symmetric, hypopigmented vitiligo-like macules, which may be present around the eyes and mouth and on the knees and penis. 13 This disease could also be associated with idiopathic torsion dystonia 13, 14 and idiopathic brain calcification. 15 Oyama et al 3 reviewed 185 DSH cases and reported that 77.6% of patients had a family history of these conditions and 22.4% had no family history. This finding is explained by sporadic cases based on spontaneous mutations or incomplete penetrance. 16 Both DUH (OMIM 127500) and DSH are inherited pigmentary skin disorders. Clinically, DUH is difficult to differentiate from DSH; however, DUH skin lesions appear within the first month of life and predominantly on the trunk, whereas the age at onset of DSH is approximately 6 years, and the skin eruptions are mainly distributed on the extremities of the hands and feet. In this study, 2 DSH families were consistent with autosomal dominant inheritance, and skin eruptions occurred mainly on the dorsal aspects of the extremities. The patients developed typical skin lesions at approximately age 10 years. Apart from the skin lesions, there are no common associated disorders in these patients. 
